Telix Pharmaceuticals sued for securities fraud, class action filed.

martes, 11 de noviembre de 2025, 10:22 am ET1 min de lectura
TLX--

A class-action lawsuit has been filed against Telix Pharmaceuticals Limited regarding alleged securities fraud between February 21, 2025 and August 28, 2025. Investors who suffered losses are encouraged to contact Brandon Walker of Bragar Eagel & Squire to discuss their options. The lawsuit claims that Telix made false and misleading statements during the Class Period.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios